Despite macroeconomic challenges, the biotech industry has demonstrated resilience and growth through innovation, demand, and technological advancements, thereby contributing to global healthcare and improving quality of life.
Given the industry’s growth prospects, investors could consider buying fundamentally sound biotech stocks Equillium, Inc. (EQ), Shionogi & Co., Ltd. (SGIOY), and Theratechnologies Inc. (THTX) for solid returns.
